421 related articles for article (PubMed ID: 28285153)
81. Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial.
Caplan MR; Landovitz RJ; Palanee-Phillips T; Nair G; Mhlanga F; Balkus JE; Riddler SA; Gorbach PM
AIDS Care; 2019 Jun; 31(6):746-753. PubMed ID: 30759997
[TBL] [Abstract][Full Text] [Related]
82. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
83. Reliance on condoms for contraceptive protection among HIV care and treatment clients: a mixed methods study on contraceptive choice and motivation within a generalised epidemic.
Church K; Wringe A; Fakudze P; Kikuvi J; Nhlabatsi Z; Masuku R; ; Mayhew SH
Sex Transm Infect; 2014 Aug; 90(5):394-400. PubMed ID: 24695990
[TBL] [Abstract][Full Text] [Related]
84. [Contraceptive use and incidence of pregnancy among women after HIV testing in Abidjan, Ivory Coast].
Brou H; Viho I; Djohan G; Ekouévi DK; Zanou B; Leroy V; Desgrées-du-Loû A;
Rev Epidemiol Sante Publique; 2009 Apr; 57(2):77-86. PubMed ID: 19304422
[TBL] [Abstract][Full Text] [Related]
85. Differences in contraceptive use between family planning providers and the U.S. population: results of a nationwide survey.
Stern LF; Simons HR; Kohn JE; Debevec EJ; Morfesis JM; Patel AA
Contraception; 2015 Jun; 91(6):464-9. PubMed ID: 25722074
[TBL] [Abstract][Full Text] [Related]
86. Contraceptive practices and trends in France.
Toulemon L; Leridon H
Fam Plann Perspect; 1998; 30(3):114-20. PubMed ID: 9635259
[TBL] [Abstract][Full Text] [Related]
87. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
Pyra M; Lingappa JR; Heffron R; Erikson DW; Blue SW; Patel RC; Nanda K; Rees H; Mugo NR; Davis NL; Kourtis AP; Baeten JM;
Contraception; 2018 Apr; 97(4):357-362. PubMed ID: 29408422
[TBL] [Abstract][Full Text] [Related]
88. Use of contraception among women who request first trimester pregnancy termination in Norway.
Strøm-Roum EM; Lid J; Eskild A
Contraception; 2016 Aug; 94(2):181-6. PubMed ID: 27091722
[TBL] [Abstract][Full Text] [Related]
89. Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia.
Reta MM; Tessema GA; Shiferaw G
BMC Res Notes; 2019 Jan; 12(1):36. PubMed ID: 30658683
[TBL] [Abstract][Full Text] [Related]
90. The role of counseling on modern contraceptive utilization among HIV positive women: the case of Northwest Ethiopia.
Araya BM; Solomon AA; Gebreslasie KZ; Gudayu TW; Anteneh KT
BMC Womens Health; 2018 Jul; 18(1):121. PubMed ID: 29973171
[TBL] [Abstract][Full Text] [Related]
91. Women's Contraceptive Preference-Use Mismatch.
He K; Dalton VK; Zochowski MK; Hall KS
J Womens Health (Larchmt); 2017 Jun; 26(6):692-701. PubMed ID: 27710196
[TBL] [Abstract][Full Text] [Related]
92. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
93. Who uses long-acting reversible contraception? Profile of LARC users in the CUPID cohort.
Coombe J; Harris ML; Loxton D
Sex Reprod Healthc; 2017 Mar; 11():19-24. PubMed ID: 28159123
[TBL] [Abstract][Full Text] [Related]
94. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
Smith AJB; Harney KF; Singh T; Hurwitz AG
J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
[TBL] [Abstract][Full Text] [Related]
95. Contraceptive use among HIV-positive women in Quang Ninh province, Vietnam.
Chi BK; Gammeltoft T; Hanh NT; Rasch V
Trop Med Int Health; 2012 Oct; 17(10):1227-34. PubMed ID: 22845648
[TBL] [Abstract][Full Text] [Related]
96. Contraception after delivery and short interpregnancy intervals among women in the United States.
White K; Teal SB; Potter JE
Obstet Gynecol; 2015 Jun; 125(6):1471-1477. PubMed ID: 26000519
[TBL] [Abstract][Full Text] [Related]
97. Factors associated with sterilization among HIV-positive US women in an urban outpatient clinic.
Raziano VT; Smoots AN; Haddad LB; Wall KM
AIDS Care; 2017 May; 29(5):612-617. PubMed ID: 27915483
[TBL] [Abstract][Full Text] [Related]
98. Population-based study of fertility in women with HIV-1 infection in Uganda.
Gray RH; Wawer MJ; Serwadda D; Sewankambo N; Li C; Wabwire-Mangen F; Paxton L; Kiwanuka N; Kigozi G; Konde-Lule J; Quinn TC; Gaydos CA; McNairn D
Lancet; 1998 Jan; 351(9096):98-103. PubMed ID: 9439494
[TBL] [Abstract][Full Text] [Related]
99. To use or not to use a condom: a prospective cohort study comparing contraceptive practices among HIV-infected and HIV-negative youth in Uganda.
Beyeza-Kashesya J; Kaharuza F; Ekström AM; Neema S; Kulane A; Mirembe F
BMC Infect Dis; 2011 May; 11():144. PubMed ID: 21605418
[TBL] [Abstract][Full Text] [Related]
100. Family planning practices and pregnancy intentions among HIV-positive and HIV-negative postpartum women in Swaziland: a cross sectional survey.
Warren CE; Abuya T; Askew I;
BMC Pregnancy Childbirth; 2013 Jul; 13():150. PubMed ID: 23855776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
